Germany Vaccine Output To Surge By $3.14 Billion By 2029.

BioNTech and CureVac, two German mRNA companies, have agreed to offer Germany with vaccines for future medical catastrophes for the next many years. Reuters reported that Germany would pay up to 2.86 billion euros to tie in local vaccine...

Exodus of Pharma Companies From Russia Due To The Ukrainian War.

Hundreds of businesses have announced a suspension or withdrawal of operations in Russia since its invasion of Ukraine. Some of the most recent companies to join the increasing list were Eli Lilly, Novartis, and AbbVie....

NHS Approves Game-Changing Drug For Blood Cancer Patients.

Thanks to a deal reached by NHS England, a targeted new medicine for a rare and severe form of lung cancer will be accessible to qualified patients within weeks. Mobocertinib, the only precision medicine accessible to patients with a mutation-driven, extreme version...

AstraZeneca Takes Steps Towards Ovarian Cancer Survival.

Only about half of women infected with ovarian cancer survive five years after diagnosis. AstraZeneca is partnering with a group of doctors and a network of patient advocacy groups to try to reverse...

Present Status of US On COVID-19 Vaccines For KIDS Under 5.

After the US Food and Drug Administration postponed essential steps toward legalising COVID-19 vaccinations for children under the age of five by a month, many parents are more eager and enthused than ever. People are driving in from multiple...

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries.

Akston Biosciences Corporation and Biolexis, a division of Stelis Biopharma Limited announced that they have entered into a licensing, manufacturing and commercialization agreement for Akston...

Pfizer to supply UNICEF up to 4 million treatment courses of novel Covid-19 oral treatment, Paxlovid for low- and middle-income countries.

Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its Covid-19 oral treatment to 95 low- and middle-income countries...